UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Renal cell carcinoma

JAMA : the journal of the American Medical Association, 2004-07, Vol.292 (1), p.97

Curti, Brendan D

2004

Volltextzugriff (PDF)

Alterations in T cell receptor and signal transduction molecules in melanoma patients

Clinical cancer research, 1995-11, Vol.1 (11), p.1327-1335

1995

Volltextzugriff (PDF)

Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients : changes during treatment

Cancer research (Chicago, Ill.), 1993-05, Vol.53 (10), p.2204-2207

1993

Volltextzugriff (PDF)

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

Journal of clinical oncology, 1992-07, Vol.10 (7), p.1141-1152

1992

Volltextzugriff (PDF)

Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer

Journal of clinical oncology, 1998-08, Vol.16 (8), p.2752-2760

1998

Volltextzugriff (PDF)

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

The New England journal of medicine, 1993-03, Vol.328 (11), p.756-761

1993

Volltextzugriff (PDF)

Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus

American journal of clinical pathology, 1998, Vol.109 (1), p.90-95

1998

Volltextzugriff (PDF)

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma

Blood, 2001-04, Vol.97 (7), p.1942-1946

2001

Volltextzugriff (PDF)

Abrogation of the Hematological and Biological Activities of the Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein PIXY321 by Neutralizing Anti-PIXY321 Antibodies in Cancer Patients Receiving High-Dose Carboplatin

Blood, 1999-05, Vol.93 (10), p.3250-3258

1999

Volltextzugriff (PDF)

Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study

The cancer journal (Sudbury, Mass.), 2000-05, Vol.6 (3), p.146

2000

Volltextzugriff (PDF)

Treatment with Tumor Necrosis Factor-α and Granulocyte–Macrophage Colony-Stimulating Factor Increases Epidermal Langerhans' Cell Numbers in Cancer Patients

Clinical immunology (Orlando, Fla.), 1999-12, Vol.93 (3), p.209-221

1999

Volltextzugriff (PDF)

Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity

Blood, 1997-04, Vol.89 (7), p.2529-2536

1997

Volltextzugriff (PDF)

Physical barriers to drug delivery in tumors

Critical reviews in oncology/hematology, 1993-02, Vol.14 (1), p.29-39

Curti, Brendan D.

1993

Volltextzugriff (PDF)

Interleukin-1 in the treatment of cancer

Pharmacology & therapeutics (Oxford), 1995-01, Vol.65 (3), p.291-302

1995

Volltextzugriff (PDF)

Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients

Journal of immunotherapy (1997), 1996-07, Vol.19 (4), p.296-308

1996

Volltextzugriff (PDF)

Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancer

Journal of immunotherapy (1997), 1996-03, Vol.19 (2), p.142-148

1996

Volltextzugriff (PDF)

A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma

Journal of immunotherapy (1997), 1996-09, Vol.19 (5), p.364-374

1996

Volltextzugriff (PDF)

A phase II study of carboplatin, cisplatin, interferon-α, and tamoxifen for patients with metastatic melanoma

Cancer investigation, 1998, Vol.16 (6), p.374-380

1998

Volltextzugriff (PDF)

PHASE I/II TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, ZIDOVUDINE AND DIPYRIDAMOLE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, RENAL-CELL CARCINOMA AND MALIGNANT-MELANOMA

International journal of oncology, 1995-03

1995

Volltextzugriff (PDF)

Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia

The cancer journal from Scientific American, 2000-01, Vol.6 (1), p.21

2000

Volltextzugriff (PDF)

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Humans
(18)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Pharmacology. Drug Treatments
(13)
Female
(12)
Oncology
(12)
Antineoplastic Agents
(11)
Adult
(10)
Male
(10)
Middle Aged
(9)
Immunotherapy
(7)
Aged
(6)
Neoplasms - Drug Therapy
(5)
Animals
(4)
Antineoplastic Agents - Therapeutic Use
(4)
Hematology
(4)
Immunology
(4)
Immunotherapy, Adoptive
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Renal cell carcinoma

Alterations in T cell receptor and signal transduction molecules in melanoma patients

Interstitial pressure of subcutaneous nodules in melanoma and lymphoma patients : changes during treatment

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies

Phase I trial of anti-CD3-stimulated CD4+ T cells, infusional interleukin-2, and cyclophosphamide in patients with advanced cancer

The Effects of Treatment with Interleukin-1α on Platelet Recovery after High-Dose Carboplatin

Hepatobiliary lymphoepithelioma-like carcinoma associated with Epstein-Barr virus

A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma

Abrogation of the Hematological and Biological Activities of the Interleukin-3/Granulocyte-Macrophage Colony-Stimulating Factor Fusion Protein PIXY321 by Neutralizing Anti-PIXY321 Antibodies in Cancer Patients Receiving High-Dose Carboplatin

Combination chemotherapy followed by an immunotoxin (anti-B4-blocked ricin) in patients with indolent lymphoma: results of a phase II study

Treatment with Tumor Necrosis Factor-α and Granulocyte–Macrophage Colony-Stimulating Factor Increases Epidermal Langerhans' Cell Numbers in Cancer Patients

Adoptive transfer of anti-CD3-activated CD4+ T cells plus cyclophosphamide and liposome-encapsulated interleukin-2 cure murine MC-38 and 3LL tumors and establish tumor-specific immunity

Physical barriers to drug delivery in tumors

Interleukin-1 in the treatment of cancer

Influence of interleukin-2 regimens on circulating populations of lymphocytes after adoptive transfer of anti-CD3-stimulated T cells: results from a phase I trial in cancer patients

Endocrine effects of IL-1 alpha and beta administered in a phase I trial to patients with advanced cancer

A phase I randomized study of subcutaneous adjuvant IL-2 in combination with an autologous tumor vaccine in patients with advanced renal cell carcinoma

A phase II study of carboplatin, cisplatin, interferon-α, and tamoxifen for patients with metastatic melanoma

PHASE I/II TRIAL OF 5-FLUOROURACIL, LEUCOVORIN, ZIDOVUDINE AND DIPYRIDAMOLE FOR PATIENTS WITH METASTATIC COLORECTAL-CANCER, RENAL-CELL CARCINOMA AND MALIGNANT-MELANOMA

Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia

Suchergebnisse filtern